Hide metadata

dc.date.accessioned2022-12-13T16:13:22Z
dc.date.available2022-12-13T16:13:22Z
dc.date.created2022-12-08T10:43:11Z
dc.date.issued2022
dc.identifier.citationSkjælaaen, Katarina Nesvold, Helle Brekke, Mette Sare, Miriam Landaas, Elisabeth Toverud Mdala, Ibrahimu Olsen, Anne Olaug Vallersnes, Odd Martin . Sexually transmitted infections among patients attending a sexual assault centre: a cohort study from Oslo, Norway. BMJ Open. 2022, 12
dc.identifier.urihttp://hdl.handle.net/10852/98154
dc.description.abstractObjectives We estimate the prevalence of sexually transmitted infection (STI) among patients after sexual assault, assess the possible value of azithromycin prophylaxis, and identify risk factors for assault-related STI and for not presenting at follow-up. Design Prospective observational cohort study. Setting Sexual assault centre in Oslo, Norway. Participants 645 patients, 602 (93.3%) women and 43 (6.7%) men, attending the centre from May 2017 to July 2019. Outcome measures Microbiological testing at the primary examination and at follow-up consultations after 2, 5 and 12 weeks. Estimated relative risk for assault-related STI and for not presenting at follow-up. Results At primary examination, the prevalence of genital chlamydia was 8.4%, Mycoplasma genitalium 6.4% and gonorrhoea 0.6%. In addition, the prevalence of bacterial STI diagnosed at follow-up and possibly from the assault was 3.0% in total: 2.5% for M. genitalium, 1.4% for genital chlamydia and 0.2% for gonorrhoea. This prevalence did not change when azithromycin was no longer recommended from January 2018. There were no new cases of hepatitis B, hepatitis C, HIV or syphilis. We found no specific risk factors for assault-related STI. Patients with previous contact with child welfare service less often presented to follow-up (relative risk (RR) 2.0 (95% CI 1.1 to 3.5)), as did patients with a history of sex work (RR 3.6 (1.2 to 11.0)) or substance abuse (RR 1.7 (1.1 to 2.7)). Conclusions Most bacterial STIs were diagnosed at the primary examination, hence not influenced by prophylaxis. There was no increase in bacterial STI diagnosed at follow-up when azithromycin prophylaxis was not routinely recommended, supporting a strategy of starting treatment only when infection is diagnosed or when the patient is considered at high risk. Sex work, substance abuse and previous contact with child welfare services were associated with not presenting to follow-up.
dc.languageEN
dc.publisherBMJ Publishing Group
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleSexually transmitted infections among patients attending a sexual assault centre: a cohort study from Oslo, Norway
dc.title.alternativeENEngelskEnglishSexually transmitted infections among patients attending a sexual assault centre: a cohort study from Oslo, Norway
dc.typeJournal article
dc.creator.authorSkjælaaen, Katarina
dc.creator.authorNesvold, Helle
dc.creator.authorBrekke, Mette
dc.creator.authorSare, Miriam
dc.creator.authorLandaas, Elisabeth Toverud
dc.creator.authorMdala, Ibrahimu
dc.creator.authorOlsen, Anne Olaug
dc.creator.authorVallersnes, Odd Martin
cristin.unitcode185,52,15,0
cristin.unitnameAvdeling for allmennmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2090531
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMJ Open&rft.volume=12&rft.spage=&rft.date=2022
dc.identifier.jtitleBMJ Open
dc.identifier.volume12
dc.identifier.issue12
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2022-064934
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2044-6055
dc.type.versionPublishedVersion
cristin.articleide064934


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International